mecamylamine has been researched along with glucagon-like peptide 1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gulec, G; Isbil-Buyukcoskun, N | 2 |
2 other study(ies) available for mecamylamine and glucagon-like peptide 1
| Article | Year |
|---|---|
Effects of intracerebroventricularly injected glucagon-like peptide-1 on cardiovascular parameters; role of central cholinergic system and vasopressin.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Antihypertensive Agents; Blood Pressure; Central Nervous System; Cholinergic Fibers; Glucagon; Glucagon-Like Peptide 1; Heart Rate; Injections, Intraventricular; Male; Mecamylamine; Muscarinic Antagonists; Nicotinic Antagonists; Peptide Fragments; Protein Precursors; Rats; Rats, Wistar; Receptors, Muscarinic; Receptors, Vasopressin; Time Factors; Vasopressins | 2004 |
Investigation of the mechanisms involved in the central effects of glucagon-like peptide-1 on ethanol-induced gastric mucosal lesions.
Topics: Animals; Atropine; Cysteamine; Ethanol; Female; Gastric Mucosa; Glucagon-Like Peptide 1; Injections, Intraventricular; Mecamylamine; Muscarinic Antagonists; Nicotinic Antagonists; Peptides; Rats; Rats, Wistar | 2005 |